Adult Pediatric Dermatology is categorized under Pediatricians in Naperville, IL and active since 1997.
Adult Pediatric Dermatology was established in 1997, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Pediatricians business, which does work in the B2C market, and is classified as a Pediatricians, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Colleen Keegan at the company’s single location by writing to 1004 Frances Court, Naperville, Illinois IL 60563 or by phoning (630) 369-3376. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Adult Pediatric Dermatology |
| Contact Person: | Colleen Keegan |
| Address: | 1004 Frances Court, Naperville, Illinois 60563 |
| Phone Number: | (630) 369-3376 |
| Website Address: | drcolleenkeegan.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1997 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Pediatricians |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Adult Pediatric Dermatology was started in 1997 to provide professional Pediatricians under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Colleen Keegan for inquiries that concern Adult Pediatric Dermatology by calling the company number (630) 369-3376, as your correspondence is most welcome. Additionally, the physical location of the single location of Adult Pediatric Dermatology can be found at the coordinates 41.786483,-88.119446 as well as the street address 1004 Frances Court in Naperville, Illinois 60563.
For its online presence, you may visit Adult Pediatric Dermatology’s website at drcolleenkeegan.com and engage with its social media outlets through on Twitter and on Facebook.